Medivation Announces Participation at Upcoming Investor Conferences

Medivation Announces Participation at Upcoming Investor Conferences 
SAN FRANCISCO, CA -- (Marketwired) -- 05/06/13 --  Medivation, Inc.
(NASDAQ: MDVN) today announced that it will present at the following
conferences: 


 
--  David Hung, M.D., president and chief executive officer, will present
    at the UBS Global Healthcare Conference on May 20 at 1pm ET at the
    Grand Hyatt in New York, NY.
--  David Hung, M.D., president and chief executive officer, will present
    at the 38th Annual dbAccess Health Care Conference on May 29 at 4:50pm
    ET at the Westin Boston Waterfront in Boston, MA.
--  Patrick Machado, chief business and financial officer, will present at
    the Jefferies 2013 Global Healthcare Conference on June 3 at 11am ET
    at the Grand Hyatt in New York, NY.
--  David Hung, M.D., president and chief executive officer, will present
    at the Goldman Sachs 34th Annual Global Healthcare Conference, on June
    11 at 4pm PT at the Terranea Resort in Rancho Palos Verdes, CA.

  
Individuals may access the live audio webcast by visiting:
http://investors.medivation.com/events.cfm. A replay of the webcast
will be available on the Company's website for 30 days following the
live event. 
About Medivation
 Medivation, Inc. is a biopharmaceutical company
focused on the rapid development of novel therapies to treat serious
diseases for which there are limited treatment options. Medivation
aims to transform the treatment of these diseases and offer hope to
critically ill patients and their families. For more information,
please visit us at www.medivation.com. 
Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101 
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900 
 
 
Press spacebar to pause and continue. Press esc to stop.